BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11119127)

  • 1. Palisading and verocay body-prominent dermatofibrosarcoma protuberans: a report of three cases.
    Llatjós R; Fernández-Figueras MT; Díaz-Cascajo C; Ribera M; Ariza A
    Histopathology; 2000 Nov; 37(5):452-5. PubMed ID: 11119127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palisading and Verocay body-prominent dermatofibrosarcoma protuberans: A case report.
    Wei S; Dumas A; Zhang PJ; Cooper K
    Pathol Res Pract; 2016 Feb; 212(2):145-7. PubMed ID: 26725533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosarcomatous dermatofibrosarcoma protuberans with giant rosettes.
    Zamecnik M
    Am J Dermatopathol; 2001 Feb; 23(1):41-5. PubMed ID: 11176051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary dermatofibrosarcoma protuberans of orbit--a rare entity.
    Rahman T; Bhattacharjee K; Sarma JD; Dey D; Kuri G
    Orbit; 2013 Apr; 32(2):127-9. PubMed ID: 23448305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrophic and plaquelike dermatofibrosarcoma protuberans.
    Davis DA; Sánchez RL
    Am J Dermatopathol; 1998 Oct; 20(5):498-501. PubMed ID: 9790114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.
    Reimann JD; Fletcher CD
    Am J Surg Pathol; 2007 Sep; 31(9):1371-7. PubMed ID: 17721193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histogenetic relations between giant cell fibroblastoma and dermatofibrosarcoma protuberans. CD34 staining showing the spectrum and a simulator.
    Harvell JD; Kilpatrick SE; White WL
    Am J Dermatopathol; 1998 Aug; 20(4):339-45. PubMed ID: 9700370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.
    Terrier-Lacombe MJ; Guillou L; Maire G; Terrier P; Vince DR; de Saint Aubain Somerhausen N; Collin F; Pedeutour F; Coindre JM
    Am J Surg Pathol; 2003 Jan; 27(1):27-39. PubMed ID: 12502925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?
    Horenstein MG; Prieto VG; Nuckols JD; Burchette JL; Shea CR
    Am J Surg Pathol; 2000 Jul; 24(7):996-1003. PubMed ID: 10895822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatofibrosarcoma Protuberans of Distal Extremities and Acral Sites: A Clinicopathologic Analysis of 27 Cases.
    Shah KK; McHugh JB; Folpe AL; Patel RM
    Am J Surg Pathol; 2018 Mar; 42(3):413-419. PubMed ID: 29240584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34 expression in desmoplastic melanoma.
    Hoang MP; Selim MA; Bentley RC; Burchette JL; Shea CR
    J Cutan Pathol; 2001 Nov; 28(10):508-12. PubMed ID: 11737519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigmented dermatofibrosarcoma protuberans with prominent meningothelial-like whorls.
    Wang J; Yang W
    J Cutan Pathol; 2008 Oct; 35 Suppl 1():65-9. PubMed ID: 18544057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMA+ cells in dermatofibrosarcoma protuberans. A study of 11 tumors suggesting perineurial cell differentiation.
    Zámecník M; Michal M
    Cesk Patol; 2002 Apr; 38(2):55-62. PubMed ID: 12426982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerosing dermatofibrosarcoma protuberans.
    Diaz-Cascajo C; Weyers W; Borghi S
    J Cutan Pathol; 1998 Sep; 25(8):440-4. PubMed ID: 9826170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatofibrosarcoma protuberans association with nuchal-type fibroma.
    Diwan AH; Horenstein MG
    J Cutan Pathol; 2004 Jan; 31(1):62-6. PubMed ID: 14675287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulated uninodular dermatofibrosarcoma protuberans of the dermis: a case report.
    Magro G; Grasso S
    Gen Diagn Pathol; 1997 Jun; 142(5-6):353-6. PubMed ID: 9228260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosarcomatous Change in a Dermatofibrosarcoma Protuberans: Significance and Implications in the Differential Diagnosis of the Coexpression of S100 Protein and CD34 in Both Components.
    Sabater-Marco V
    Am J Dermatopathol; 2020 Jan; 42(1):71-74. PubMed ID: 31884500
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
    Haycox CL; Odland PB; Olbricht SM; Piepkorn M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
    Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
    Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital atrophic dermatofibrosarcoma protuberans detected by COL1A1-PDGFB rearrangement.
    Makino M; Sasaoka S; Nakanishi G; Makino E; Fujimoto W
    Diagn Pathol; 2016 Mar; 11():24. PubMed ID: 26932148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.